<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hand, Larry</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Mont, Lluis</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Catheter Ablation Yields Greater Benefits Than Drugs in SARA Study</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-14</style></pages><abstract><style  face="normal" font="default" size="100%">In a trial with only persistent atrial fibrillation (PeAF) patients, as opposed to a combination of PeAF and paroxysmal AF patients, catheter ablation had significantly better results at 12-month follow-up than antiarrhythmic drug treatment. This article presents the results of the Study of Ablation Versus Antiarrhythmic Drugs in Persistent Atrial Fibrillation [SARA; NCT00863213].</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>